Clopidogrel Bioequivalence Study in Healthy Subjects
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This study will be an open-label, randomised, three-way crossover study in healthy male and
female subjects, performed at a single centre. The objective of the study is to assess the
bioequivalence between one test formulation (Clopidogrel 75 mg tablet (commercial blister
from KRKA) and two reference formulations (Clopidogrel 75 mg tablet [Plavix, sourced in US
and Japan]).